Dextrose (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Dextrose drug offered from Fresenius Kabi USA, LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | Dextrose Monohydrate |
| SUBSTANCE NAME: | DEXTROSE MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-10-21 |
| END MARKETING DATE: | 0000-00-00 |
Dextrose HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dextrose from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2016-10-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-624_008617d7-af80-4ecf-986b-5479b92be7a4 |
| PRODUCT NDC: | 63323-624 |
| APPLICATION NUMBER: | ANDA207449 |
Other DEXTROSE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
